Irmandade da Santa Casa de Misericordia de Porto Alegre, Nucleo de Novos Tratamentos em Cancer

Porto Alegre, Rio Grande do Sul 90050-170

0 studies enrolling now · 1 studies all time

What they study most

KRAS p.G12C Mutant Advanced Solid Tumors

Studies at this site

• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed